Factors influencing airway inflammation in chronic obstructive pulmonary disease

Thorax

Volumn 55, Issue 11, 2000, Pages 970-977

  Hill, A ^a   Gompertz, S ^a   Stockley, R ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ELASTASE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW; SMOKING;

ALPHA 1-ANTITRYPSIN DEFICIENCY; ASTHMA; BRONCHIECTASIS; BRONCHITIS; HUMANS; INFLAMMATION; LUNG DISEASES, OBSTRUCTIVE; PULMONARY EMPHYSEMA; RISK FACTORS; SMOKING; SPUTUM;

EID: 0033758619     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.11.970     Document Type: Review

References (108)

1. Eosinophils
2. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society
3. Corticosteroid reversibility in COPD is related to features of asthma
4. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis
5. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium
6. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: A serine proteinase effect
7. Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster
8. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells
9. Possible role of PMN proteinases in immunoglobulin degradation and amyloid formation
10. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch
11. Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products
12. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: Partial characterization of a hitherto unquantified inhibitor of neutrophil elastase
13. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema
14. The chemotactic activity of sputum from patients with bronchiectasis
15. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: The role of leukotriene B4
16. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line
17. Regulation of human alveolar macrophage- and blood monocyte-derived interleukin-8 by prostaglandin E2 and dexamethasone
18. Leukotriene B4 stimulates human polymorphonuclear leukocytes to synthesize and release interleukin-8 in vitro
19. Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells
20. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma
21. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis
22. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells
23. Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation
24. Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo
25. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils
26. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid
27. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease
28. Interleukin-8: An important chemoattractant in sputum of patients with chronic inflammatory airway diseases
29. Airway inflammation in COPD assessed by sputum levels of interleukin-8
30. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes
31. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
32. Neutrophil accumulation in the lung in alpha-1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages
33. Leukotriene B4
34. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction
35. Cytokine production by mast cells and basophils
36. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses
37. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha
38. Interleukin-8, interleukin-6 and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus
39. Tumor necrosis factor causes bronchial hyperresponsiveness in rats
40. Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells
41. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide
42. Combination of IL-8 plus TNF alpha induces additive neutrophil migration
43. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon
44. The pathophysiology of tumor necrosis factors
45. Inhibition of neutrophil migration by tumor necrosis factor. Ex vivo and in vivo studies in comparison with in vitro effect
46. Complement activation in cystic fibrosis respiratory fluids: In vivo and in vitro generation of C5a and chemotactic activity
47. Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis
48. 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoatractant
49. Neutrophils show chemotaxis to type IV collagen and its 7S domain and contain a 67 kD type IV collagen binding protein with lectin properties
50. Chemotactic activity of elastin-derived peptides
51. A role for the laminin receptor in leukocyte chemotaxis
52. The chemotactic effect of antibody and antigen on polymorphonuclear leukocytes
53. Degree of neutrophil chemotaxis is dependent upon the chemoattractant and barrier
54. Interaction between chemoattractants and bacterial lipopolysaccharide in the induction and enhancement of neutrophil adhesion
55. Multistep navigation and the combinatorial control of leukocyte chemotaxis
56. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes
57. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis
58. Alpha-1-antitrypsin and leukocyte elastase in infected and noninfected sputum
59. Effect of neutrophil mediators on epithelial permeability
60. Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation
61. Granulocyte activation markers in induced sputum: Comparison between chronic obstructive pulmonary disease, asthma, and normal subjects
62. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis
63. Bronchiectasis: New therapeutic approaches based on pathogenesis
64. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis
65. Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: Relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment
66. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum
67. Sputum endothelin-1 is increased in cystic fibrosis and chronic obstructive pulmonary disease
68. Chronic bronchitis: The antiproteinase/proteinase balance and the effect of infection and corticosteroids
69. Bronchial inflammation in patients with chronic bronchitis, with and without alpha-1-antitrypsin deficiency, and patients with bronchiectasis
70. 1-antitrypsin deficiency (PiZ)
71. Comparison of stable state bronchial inflammation in chronic bronchitis and previously unsuspected bronchiectasis
72. Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease
73. Changes in sputum composition between two inductions performed on consecutive days
74. Effect of repeated sputum induction on cell counts in normal volunteers
75. Comparison of two methods of processing induced sputum: Selected versus entire sputum
76. Spontaneous and induced sputum to measure indices of airway inflammation in asthma
77. Sputum induction to assess bronchial inflammation in patients with homozygous alpha-1-antitrypsin deficiency
78. Validation of assays for lung inflammatory markers
79. Induced sputum cell and fluid-phase indices of inflammation: Comparison of treatment with dithiothreitol vs phosphate-buffered saline
80. Homogenisation with dithiothreitol (DTT) influences concentrations of inflammatory mediators in sputa of asthmatics
81. Cigarettes and respiratory disease
82. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
83. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers
84. Airways obstruction, chronic expectoration, and rapid decline of FEV in smokers are associated with increased levels of sputum neutrophils
85. Severity of airflow limitation is associated with severity of airway inflammation in smokers
86. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry
87. Airways inflammation in chronic bronchitis: The effects of smoking and alpha-1-antitrypsin deficiency
88. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms
89. Studies in alpha-1-antitrypsin deficiency
90. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: Anti-elastase function and cell profile
91. The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage
92. Nonisotropic enzyme-inhibitor interactions: A novel nonoxidative mechanism for quantum proteolysis by human neutrophils
93. Quantum proteolysis resulting from release of single granules by human neutrophils: A novel, nonoxidative mechanism of extracellular proteolytic activity
94. Granulocyte-alveolar-macrophage interaction in the pulmonary clearance of Staphylococcus aureus
95. Early pulmonary granulocyte recruitment in response to Streptococcus pneumoniae
96. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae
97. Role of bacteria in the pathogenesis and progression of acute and chronic lung infection
98. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation
99. Airway bacterial load in stable chronic bronchitis: A potent stimulus for airway inflammation
100. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease
101. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
102. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis
103. Airway eosinophilia in chronic bronchitis during exacerbations
104. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
105. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
106. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema
107. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease
108. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease